The ocular renin-angiotensin system: A therapeutic target for the treatment of ocular disease

Pharmacology and Therapeutics

Volumn 142, Issue 1, 2014, Pages 11-32

  Giese, Michael J ^a   Speth, Robert C ^b  

^a Nova Southeastern University ^*  (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Angiotensin II; Eye; Glaucoma; Ocular; Renin angiotensin system; Retina

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRILAT; ENALKIREN; FOSINOPRIL; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; LOSARTAN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN LIGHT CHAIN; NEUROLYSIN; OLMESARTAN; PRORENIN; PROSTAGLANDIN E2; RAMIPRILAT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASOCONSTRICTOR AGENT;

AQUEOUS HUMOR; ARTICLE; CHOROID DISEASE; CONJUNCTIVA DISEASE; CORNEA DISEASE; DIABETIC RETINOPATHY; EYE DISEASE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; LACRIMAL GLAND DISEASE; NONHUMAN; OPEN ANGLE GLAUCOMA; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA MACULA AGE RELATED DEGENERATION; RETROLENTAL FIBROPLASIA; SARCOIDOSIS; VITREOUS BODY;

ANGIOTENSIN II; EYE; GLAUCOMA; OCULAR; RENIN-ANGIOTENSIN SYSTEM; RETINA;

ANIMALS; EYE; EYE DISEASES; HUMANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84896731431     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.11.002     Document Type: Review

References (247)

1. J. Abd Alla, Y. el Faramawy, and U. Quitterer Microarray gene expression profiling reveals antioxidant-like effects of angiotensin II inhibition in atherosclerosis Front Physiol 4 2013 148
2. L.P. Aiello, R.L. Avery, P.G. Arrigg, B.A. Keyt, H.D. Jampel, and S.T. Shah et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1994 1480 1487
3. O. Alcazar, S.W. Cousins, G.E. Striker, and M.E. Marin-Castano (Pro)renin receptor is expressed in human retinal pigment epithelium and participates in extracellular matrix remodeling Exp Eye Res 89 2009 638 647
4. E. Aydin, H.D. Demir, and S. Sahin Plasma and aqueous humor angiotensin-converting enzyme levels in patients with diabetic retinopathy Curr Eye Res 35 2010 230 234
5. M. Bader, R.A. Santos, T. Unger, and U.M. Steckelings New therapeutic pathways in the RAS J Renin Angiotensin Aldosterone Syst 13 2012 505 508
6. J.L. Berka, A.J. Stubbs, D.Z.M. Wang, R. DiNicolantonio, D. Alcorn, and D.J. Campbell et al. Renin-containing Muller cells of the retina display endocrine features Invest Ophthalmol Vis Sci 36 1995 1450 1458
7. R. Bertazolli-Filho, M. Coca-Prados, A. Haddad, and E.M. Laicine Molecular analysis of neurolysin expression in the rat and bovine ciliary body Curr Eye Res 32 2007 751 756
8. J.J. Boffa, Y. Lu, S. Placier, A. Stefanski, J.C. Dussaule, and C. Chatziantoniou Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases J Am Soc Nephrol 14 2003 1132 1144
9. L. Bonomi, G. Marchini, M. Marraffa, P. Bernardi, R. Morbio, and A. Varotto Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study Ophthalmology 107 2000 1287 1293
10. D. Borovic, E. Bendelic, and D. Chiselita Study of kini-kallikrein and renin-angiotensin systems in patients with primary open angle glaucoma Oftalmologia 53 2009 61 68
11. C.R. Brandt, A.M. Pumfery, B. Micales, C.D. Bindley, G.E. Lyons, and S.J. Sramek et al. Renin mRNA is synthesized locally in rat ocular tissues Curr Eye Res 13 1994 755 763
12. C. Bucolo, and F. Drago Carbon monoxide and the eye: implications for glaucoma therapy Pharmacol Ther 130 2011 191 201
13. C. Bucolo, S. Salomone, F. Drago, M. Reibaldi, A. Longo, and M.G. Uva Pharmacological management of ocular hypertension: current approaches and future prospective Curr Opin Pharmacol 13 2013 50 55
14. B.V. Bui, J.A. Armitage, M. Tolcos, M.E. Cooper, and A.J. Vingrys ACE inhibition salvages the visual loss caused by diabetes Diabetologia 46 2003 401 408
15. D.J. Campbell Circulating and tissue angiotensin systems J Clin Invest 79 1987 1 6
16. R.R. Caspi Immune mechanisms in uveitis Springer Semin Immunopathol 21 1999 113 124
17. N. Chaturvedi, M. Porta, R. Klein, T. Orchard, J. Fuller, and H.H. Parving et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials Lancet 372 2008 1394 1402
18. N. Chaturvedi, A.K. Sjolie, J.M. Stephenson, H. Abrahamian, M. Keipes, and A. Castellaran et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes Lancet 351 1998 28 31
19. P. Chen, G.M. Scicli, M. Guo, J.D. Fenstermacher, D. Dahl, and P.A. Edwards et al. Role of angiotensin II in retinal leukostasis in the diabetic rat Exp Eye Res 83 2006 1041 1051
20. N.B. Chesnokova, O.A. Kost, I.I. Nikol'skaia, O.V. Beznos, P.V. Binevskii, and P.V. Makarov et al. Experimental rationale for local use of angiotensin-converting enzyme inhibitors for the treatment of ocular tissue ischemia on a model of postburn conjunctival ischemia Vestn Oftalmol 124 2008 28 31
21. N.B. Chesnokova, O.A. Kost, I.I. Nikol'skaia, O.V. Beznos, P.V. Binevskii, and E.P. Stoliarova et al. Mental rationale for local use of angiotensin-converting enzyme in the treatment of inflammatory processes in the eye Vestn Oftalmol 124 2008 16 19
22. A. Ciudin, C. Hernandez, and R. Simo Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms? Exp Diabetes Res 2010 10.1155/2010/714108 (pii: 714108)
23. T.A. Ciulla, A.G. Amador, and B. Zinman Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies Diabetes Care 26 2003 2653 2664
24. M. Coca-Prados, and J. Escribano New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland Prog Retin Eye Res 26 2007 239 262
25. W.H. Constad, P. Fiore, C. Samson, and A.A. Cinotti Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma Am J Ophthalmol 105 1988 674 677
26. C. Costagliola, B.R. Di, C.L. De, R. Verde, and L. Mastropasqua Effect of oral captopril (SQ 14225) on intraocular pressure in man Eur J Ophthalmol 5 1995 19 25
27. C. Costagliola, M. Verolino, M.L. De Rosa, G. Iaccarino, M. Ciancaglini, and L. Mastropasqua Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects Exp Eye Res 71 2000 167 171
28. A.B. Cullinane, P.S. Leung, J. Ortego, M. Coca-Prados, and B.J. Harvey Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium Br J Ophthalmol 86 2002 676 683
29. A.H. Danser, F.H. Derkx, P.J. Admiraal, J. Deinum, P.T. de Jong, and M.A. Schalekamp Angiotensin levels in the eye Invest Ophthalmol Vis Sci 35 1994 1008 1018
30. A.H. Danser, M.A. van den Dorpel, J. Deinum, F.H. Derkx, A.A. Franken, and E. Peperkamp et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy J Clin Endocrinol Metab 68 1989 160 167
31. N.M. Davies, P.G. Kehoe, Y. Ben-Shlomo, and R.M. Martin Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias J Alzheimers Dis 26 2011 699 708
32. M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International union of pharmacology. XXIII. The angiotensin II receptors Pharmacol Rev 52 2000 415 472
33. J. Deinum, F.H. Derkx, A.H. Danser, and M.A. Schalekamp Identification and quantification of renin and prorenin in the bovine eye Endocrinology 126 1990 1673 1682
34. D. Deliyanti, A.G. Miller, G. Tan, K.J. Binger, A.L. Samson, and J.L. Wilkinson-Berka Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy Hypertension 59 2012 607 613
35. P. Demurtas, G.N. Di, M. Corrias, I. Zucca, C. Maxia, and A. Diana et al. Immunohistochemical analysis of angiotensin converting enzyme in Sardinian pterygium Histol Histopathol 28 2013 759 766
36. I. Dielemans, J.R. Vingerling, D. Algra, A. Hofman, D.E. Grobbee, and P.T. de Jong Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study Ophthalmology 102 1995 54 60
37. L.E. Downie, M.J. Pianta, A.J. Vingrys, J.L. Wilkinson-Berka, and E.L. Fletcher AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy Glia 56 2008 1076 1090
38. L.E. Downie, K. Vessey, A. Miller, M.M. Ward, M.J. Pianta, and A.J. Vingrys et al. Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina Neuroscience 161 2009 195 213
39. R.O. Estacio, B.W. Jeffers, N. Gifford, and R.W. Schrier Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes Diabetes Care 23 Suppl. 2 2000 B54 B64
40. M. Evans, O. Sharma, L. LaBree, R.E. Smith, and N.A. Rao Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis Ophthalmology 114 2007 325 333
41. Y. Fang, D. Choi, R.P. Searles, and W.D. Mathers A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma Invest Ophthalmol Vis Sci 46 2005 461 469
42. S.S. Feman, R.A. Mericle, G.W. Reed, J.M. May, and R.J. Workman Serum angiotensin converting enzyme in diabetic patients Am J Med Sci 305 1993 280 284
43. G. Ferrari-Dileo, E.B. Davis, and D.R. Anderson Angiotensin II binding receptors in retinal and optic nerve head blood vessels. An autoradiographic approach Invest Ophthalmol Vis Sci 32 1991 21 26
44. G. Ferrari-Dileo, E.B. Davis, and D.R. Anderson Glaucoma, capillaries and pericytes. 3. Peptide hormone binding and influence on pericytes Ophthalmologica 210 1996 269 275
45. G. Ferrari-Dileo, J.W. Ryan, E.J. Rockwood, E.B. Davis, and D.R. Anderson Angiotensin-converting enzyme in bovine, feline, and human ocular tissues Invest Ophthalmol Vis Sci 29 6 1988 876 881
46. E.L. Fletcher, J.A. Phipps, M.M. Ward, K.A. Vessey, and J.L. Wilkinson-Berka The renin-angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature Prog Retin Eye Res 29 2010 284 311
47. A.A. Franken, F.H. Derkx, M.A. Schalekamp, A.J. Man in t'Veld, W.C. Hop, and E.H. van Rens et al. Association of high plasma prorenin with diabetic retinopathy J Hypertens Suppl. 6 1988 S461 S463
48. T.F. Freddo A contemporary concept of the blood-aqueous barrier Prog Retin Eye Res 32 2013 181 195
49. R. Funk, and J.W. Rohen Comparative morphological studies on blood vessels in eyes of normotensive and spontaneously hypertensive rats Exp Eye Res 40 1985 191 203
50. R. Funk, and J.W. Rohen Scanning electron microscopic study on the vasculature of the human anterior eye segment, especially with respect to the ciliary processes Exp Eye Res 51 1990 651 661
51. I. Gabriely, X.M. Yang, J.A. Cases, X.H. Ma, L. Rossetti, and N. Barzilai Hyperglycemia modulates angiotensinogen gene expression Am J Physiol Regul Integr Comp Physiol 281 2001 R795 R802
52. B.B. Gao, X. Chen, N. Timothy, L.P. Aiello, and E.P. Feener Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy J Proteome Res 7 2008 2516 2525
53. L. Geng, K. Persson, and S.F. Nilsson Angiotensin converting anzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors J Ocul Pharmacol Ther 19 2003 589 598
54. C. Gerhardinger, M.B. Costa, M.C. Coulombe, I. Toth, T. Hoehn, and P. Grosu Expression of acute-phase response proteins in retinal Muller cells in diabetes Invest Ophthalmol Vis Sci 46 2005 349 357
55. W.J. Giardina, H.D. Kleinert, D.M. Ebert, C.T. Wismer, M.A. Chekal, and H.H. Stein Intraocular pressure lowering effects of the renin inhibitor ABBOTT-64662 diacetate in animals J Ocul Pharmacol 6 1990 75 83
56. R.E. Gilbert, D.J. Kelly, A.J. Cox, J.L. Wilkinson-Berka, J.R. Rumble, and T. Osicka et al. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes Diabetologia 43 2000 1360 1367
57. G. Gnanaguru, and W.J. Brunken The cell-matrix interface: a possible target for treating retinal vascular related pathologies J Ophthalmic Vis Res 7 2012 316 327
58. W.V. Good, R.J. Hardy, V. Dobson, E.A. Palmer, D.L. Phelps, and M. Quintos et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study Pediatrics 116 2005 15 23
59. G.H. Goossens The renin-angiotensin system in the pathophysiology of type 2 diabetes Obes Facts 5 2012 611 624
60. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, and R.W. Alexander Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ Res 74 1994 1141 1148
61. E. Guenther, B. Hewig, E. Zrenner, and K. Kohler Angiotensin II-induced inhibition and facilitation of calcium current subtypes in rat retinal ganglion cells Neurosci Lett 231 1997 71 74
62. H. Hara, K. Oh-hashi, S. Yoneda, M. Shimazawa, M. Inatani, and H. Tanihara et al. Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy Mol Vis 12 2006 977 982
63. T. Harindhanavudhi, M. Mauer, R. Klein, B. Zinman, A. Sinaiko, and M.L. Caramori Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control Diabetes Care 34 2011 1838 1842
64. Z. He, C.T. Nguyen, J.A. Armitage, A.J. Vingrys, and B.V. Bui Blood pressure modifies retinal susceptibility to intraocular pressure elevation PLoS One 7 2012 e31104
65. Z. He, A.J. Vingrys, J.A. Armitage, and B.V. Bui The role of blood pressure in glaucoma Clin Exp Optom 94 2011 133 149
66. S. Higuchi, H. Ohtsu, H. Suzuki, H. Shirai, G.D. Frank, and S. Eguchi Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology Clin Sci (Lond) 112 2007 417 428
67. T. Hikichi, F. Mori, A. Takamiya, M. Sasaki, Y. Horikawa, and M. Takeda et al. Inhibitory effect of losartan on laser-induced choroidal neovascularization in rats Am J Ophthalmol 132 2001 587 589
68. K. Hirooka, T. Baba, T. Fujimura, and F. Shiraga Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma Am J Ophthalmol 142 2006 523 525
69. N. Horio, A.C. Clermont, A. Abiko, T. Abiko, B.D. Shoelson, and S.E. Bursell et al. Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats Diabetologia 47 2004 113 123
70. Y. Hou, and N.A. Delamere Influence of ANG II on cytoplasmic sodium in cultured rabbit nonpigmented ciliary epithelium Am J Physiol Cell Physiol 283 2002 C552 C559
71. A.J. Houben, J.P. Burgwinkel, and P.W. de Leeuw A novel approach to the study of human microcirculation: reactivity to locally applied angiotensin II in the conjunctival microvascular bed J Hypertens 24 2006 2225 2230
72. A. Ichihara, M. Hayashi, Y. Kaneshiro, F. Suzuki, T. Nakagawa, and Y. Tada et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin J Clin Invest 114 2004 1128 1135
73. R. Igic, and V. Kojovic Angiotensin I converting enzyme (kininase II) in ocular tissues Exp Eye Res 30 1980 299 303
74. R. Igic, L. Wania-Galicia, and H.L. Jackman Metabolism of angiotensin I by guinea pig aqueous humor Can J Physiol Pharmacol 79 2001 627 630
75. I. Ilieva, K. Ohgami, X.H. Jin, Y. Suzuki, K. Shiratori, and K. Yoshida et al. Captopril suppresses inflammation in endotoxin-induced uveitis in rats Exp Eye Res 83 2006 651 657
76. I. Immonen, K. Friberg, R. Sorsila, and F. Fyhrquist Concentration of angiotensin-converting enzyme in tears of patients with sarcoidosis Acta Ophthalmol (Copenh) 65 1987 27 29
77. T. Inoue, T. Yokoyoma, and H. Koike The effect of angiotensin II on uveoscleral outflow in rabbits Curr Eye Res 23 2001 139 143
78. T. Inoue, T. Yokoyoma, Y. Mori, Y. Sasaki, T. Hosokawa, and H. Yanagisawa et al. The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits Curr Eye Res 23 2001 133 138
79. T. Ishibashi, Y. Hata, H. Yoshikawa, K. Nakagawa, K. Sueishi, and H. Inomata Expression of vascular endothelial growth factor in experimental choroidal neovascularization Graefes Arch Clin Exp Ophthalmol 235 1997 159 167
80. E. Ishizaki, S. Takai, M. Ueki, T. Maeno, M. Maruichi, and T. Sugiyama et al. Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy Am J Ophthalmol 141 2006 129 134
81. A. Jablecka, E. Czaplicka, J. Olszewski, P. Bogdanski, H. Krauss, and I. Smolarek Influence of selected angiotensin-converting enzyme inhibitors on alloxan-induced diabetic cataract in rabbits Med Sci Monit 15 2009 BR334 BR338
82. P.C. Jacobi, H. Osswald, B. Jurklies, and E. Zrenner Neuromodulatory effects of the renin-angiotensin system on the cat electroretinogram Invest Ophthalmol Vis Sci 35 1994 973 980
83. Y.P. Jarajapu, A.D. Bhatwadekar, S. Caballero, S. Hazra, V. Shenoy, and R. Medina et al. Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors Diabetes 62 2013 1258 1269
84. R.O. Kacmaz, J.H. Kempen, C. Newcomb, S. Gangaputra, E. Daniel, and G.A. Levy-Clarke et al. Ocular inflammation in Behcet disease: incidence of ocular complications and of loss of visual acuity Am J Ophthalmol 146 2008 828 836
85. A. Kanda, K. Noda, W. Saito, and S. Ishida (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy Diabetologia 55 2012 3104 3113
86. H. Kato, H. Suzuki, S. Tajima, Y. Ogata, T. Tominaga, and A. Sato et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells J Hypertens 9 1991 17 22
87. P.L. Kaufman, and E.H. Barany Adrenergic drug effects on aqueous outflow facility following ciliary muscle retrodisplacement in the cynomolgus monkey Invest Ophthalmol Vis Sci 20 1981 644 651
88. H. Kawamura, M. Kobayashi, Q. Li, S. Yamanishi, K. Katsumura, and M. Minami et al. Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina J Physiol 561 2004 671 683
89. B. Kennon, and J.M. Connell ACE gene polymorphism and diabetic complications: is there a connection? BioDrugs 14 2000 73 81
90. T. Kida, T. Ikeda, M. Nishimura, T. Sugiyama, Y. Imamura, and C. Sotozono et al. Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human muller cells Jpn J Ophthalmol 47 2003 36 41
91. J.H. Kim, J.H. Kim, Y.S. Yu, C.S. Cho, and K.W. Kim Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy J Cereb Blood Flow Metab 29 2009 621 628
92. K. Kohler, T. Wheeler-Schilling, B. Jurklies, E. Guenther, and E. Zrenner Angiotensin II in the rabbit retina Vis Neurosci 14 1997 63 71
93. S. Kojima, T. Sugiyama, S. Takai, D. Jin, M. Shibata, and H. Oku et al. Effects of gelatin hydrogel containing chymase inhibitor on scarring in a canine filtration surgery model Invest Ophthalmol Vis Sci 52 2011 7672 7680
94. K. Krejcy, M. Wolzt, C. Kreuzer, H. Breiteneder, W. Schutz, and H.G. Eichler et al. Characterization of angiotensin-II effects on cerebral and ocular circulation by noninvasive methods Br J Clin Pharmacol 43 1997 501 508
95. M. Krop, X. Lu, A.H. Danser, and M.E. Meima The (pro)renin receptor. A decade of research: what have we learned? Pflugers Arch 465 2013 87 97
96. T. Kurihara, Y. Ozawa, S. Ishida, H. Okano, and K. Tsubota Renin-angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction Int J Inflamm 2012 2012 581695
97. T. Kurihara, Y. Ozawa, K. Shinoda, N. Nagai, M. Inoue, and Y. Oike et al. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation Invest Ophthalmol Vis Sci 47 2006 5545 5552
98. M.J. Langman, R.J. Lancashire, K.K. Cheng, and P.M. Stewart Systemic hypertension and glaucoma: mechanisms in common and co-occurrence Br J Ophthalmol 89 2005 960 963
99. S. Lee, and N.R. Harris Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice Microcirculation 15 2008 379 387
100. C. Lin, R.A. Stone, and M.B. Wax Angiotensin binding sites in rabbit anterior uvea and human ciliary epithelial cells Invest Ophthalmol Vis Sci 31 1990 147 152
101. M.D. Lograno, and A. Reibaldi Receptor-responses in fresh human ciliary muscle Br J Pharmacol 87 1986 379 385
102. M. Lonchampt, L. Pennel, and J. Duhault Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II Invest Ophthalmol Vis Sci 42 2001 429 432
103. V.J. Lotti, and N. Pawlowski Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys J Ocul Pharmacol 6 1990 1 7
104. J.A. Luetscher, F.B. Kraemer, D.M. Wilson, H.C. Schwartz, and M. Bryer-Ash Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications N Engl J Med 312 1985 1412 1417
105. S. Luhtala, A. Vaajanen, O. Oksala, J. Valjakka, and H. Vapaatalo Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues J Ocul Pharmacol Ther 25 2009 23 28
106. P. Mallorga, R.W. Babilon, and M.F. Sugrue Angiotensin II receptors labelled with 125I-[Sar1, Ile8]-AII in albino rabbit ocular tissues Curr Eye Res 8 1989 841 849
107. M. Maruichi, S. Takai, T. Sugiyama, M. Ueki, H. Oku, and M. Sakaguchi et al. Role of chymase on growth of cultured canine Tenon's capsule fibroblasts and scarring in a canine conjunctival flap model Exp Eye Res 79 2004 111 118
108. T. Matsugi, Q. Chen, and D.R. Anderson Contractile responses of cultured bovine retinal pericytes to angiotensin II Arch Ophthalmol 115 1997 1281 1285
109. B. Matulla, G. Streit, S. Pieh, O. Findl, J. Entlicher, and U. Graselli et al. Effects of losartan on cerebral and ocular circulation in healthy subjects Br J Clin Pharmacol 44 1997 369 375
110. M. Mauer, B. Zinman, R. Gardiner, S. Suissa, A. Sinaiko, and T. Strand et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes N Engl J Med 361 2009 40 51
111. K.C. McKenna, K.M. Beatty, R.C. Scherder, F. Li, H. Liu, and A.F. Chen et al. Ascorbate in aqueous humor augments nitric oxide production by macrophages J Immunol 190 2013 556 564
112. M.J. McKinley, A.L. Albiston, A.M. Allen, M.L. Mathai, C.N. May, and R.M. McAllen et al. The brain renin-angiotensin system: location and physiological roles Int J Biochem Cell Biol 35 2003 901 918
113. E.A. McPherson, Z. Luo, R.A. Brown, L.S. LeBard, C.C. Corless, and R.C. Speth et al. Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease J Am Soc Nephrol 15 2004 493 500
114. A. Mehta, L. Iyer, S. Parmar, G. Shah, and R. Goyal Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits Can J Physiol Pharmacol 8 2010 595 600
115. F. Memarzadeh, M. Ying-Lai, J. Chung, S.P. Azen, and R. Varma Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study Invest Ophthalmol Vis Sci 51 2010 2872 2877
116. P. Meyer, J. Flammer, and T.F. Luscher Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists Invest Ophthalmol Vis Sci 36 1995 555 562
117. V.M. Milenkovic, M. Brockmann, C. Meyer, M. Desch, F. Schweda, and A. Kurtz et al. Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli Am J Physiol Renal Physiol 299 2010 F396 F403
118. A.G. Miller, G. Tan, K.J. Binger, R.J. Pickering, M.C. Thomas, and R.H. Nagaraj et al. Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function Diabetes 59 2010 3208 3215
119. M.L. Mira, M.M. Silva, M.J. Queiroz, and C.F. Manso Angiotensin converting enzyme inhibitors as oxygen free radical scavengers Free Radic Res Commun 19 1993 173 181
120. P. Mitchell, A.J. Lee, E. Rochtchina, and J.J. Wang Open-angle glaucoma and systemic hypertension: the Blue Mountains Eye Study J Glaucoma 13 2004 319 326
121. A. Miyazaki, N. Kitaichi, K. Ohgami, D. Iwata, X.H. Jin, and K. Iwabuchi et al. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats Graefes Arch Clin Exp Ophthalmol 246 2008 747 757
122. S. Mizoue, M. Iwai, A. Ide, J. Suzuki, M. Horiuchi, and A. Shiraishi et al. Role of angiotensin II receptor subtypes in conjunctival wound healing Curr Eye Res 31 2006 129 136
123. S. Mohamed, K. Schaa, M.E. Cooper, E. Ahrens, A. Alvarado, and T. Colaizy et al. Genetic contributions to the development of retinopathy of prematurity Pediatr Res 65 2009 193 197
124. C.J. Moravski, D.J. Kelly, M.E. Cooper, R.E. Gilbert, J.F. Bertram, and S. Shahinfar et al. Retinal neovascularization is prevented by blockade of the renin-angiotensin system Hypertension 36 2000 1099 1104
125. C.J. Moravski, S.L. Skinner, A.J. Stubbs, S. Sarlos, D.J. Kelly, and M.E. Cooper et al. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies Am J Pathol 162 2003 151 160
126. F. Mori, T. Hikichi, T. Nagaoka, J. Takahashi, N. Kitaya, and A. Yoshida Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats Br J Ophthalmol 86 2002 1172 1174
127. S.E. Moss, R. Klein, and B.E. Klein Long-term incidence of dry eye in an older population Optom Vis Sci 85 2008 668 674
128. S.E. Moss, R. Klein, A.K. Sjolie, N. Chaturvedi, A.R. Malm, and J.H. Fuller et al. Angiotensin receptor blockade not related to history of dry eye symptoms and treatment in The Diabetic Retinopathy Candesartan Trials (DIRECT) Acta Ophthalmol 89 2011 e535 e536
129. J.A. Nadal, G.M. Scicli, L.A. Carbini, J.J. Nussbaum, and A.G. Scicli Angiotensin II and retinal pericytes migration Biochem Biophys Res Commun 266 1999 382 385
130. N. Nagai, K. Izumi-Nagai, Y. Oike, T. Koto, S. Satofuka, and Y. Ozawa et al. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway Invest Ophthalmol Vis Sci 48 2007 4342 4350
131. N. Nagai, K. Noda, T. Urano, Y. Kubota, H. Shinoda, and T. Koto et al. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor Invest Ophthalmol Vis Sci 46 2005 1078 1084
132. N. Nagai, Y. Oike, K. Izumi-Nagai, T. Koto, S. Satofuka, and H. Shinoda et al. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin Invest Ophthalmol Vis Sci 48 2007 2321 2326
133. N. Nagai, Y. Oike, K. Izumi-Nagai, T. Urano, Y. Kubota, and K. Noda et al. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization Arterioscler Thromb Vasc Biol 26 2006 2252 2259
134. N. Nagai, Y. Oike, K. Noda, T. Urano, Y. Kubota, and Y. Ozawa et al. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor Invest Ophthalmol Vis Sci 46 2005 2925 2931
135. M. Nagano, M. Taneguchi, and Y. Hirota A trial of captopril treatment for sarcoidosis Jikeikai Med J 38 1991 351 360
136. T. Nakanishi, R. Koyama, T. Ikeda, and A. Shimizu Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole J Chromatogr B Analyt Technol Biomed Life Sci 776 2002 89 100
137. R. Natarajan, W. Bai, L. Lanting, N. Gonzales, and J. Nadler Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells Am J Physiol Heart Circ Physiol 42 1997 H2224 H2231
138. H.M. Neels, D.A. Vanden Berghe, A.J. Neetens, R.A. Delgadillo, and S.L. Scharpe Angiotensin I converting enzyme activity in rabbit corneal endothelial cells Ophthalmologica 187 1983 129 132
139. G. Nguyen Renin, (pro)renin and receptor: an update Clin Sci (Lond) 120 2011 169 178
140. G. Nguyen, F. Delarue, C. Burckle, L. Bouzhir, T. Giller, and J.D. Sraer Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin J Clin Invest 109 2002 1417 1427
141. M.L. Nunes-Mamede, F.G. De Mello, and A.R. Martins In ovo and in culture development of chick retinal angiotensin converting enzyme Neurosci Lett 109 1990 174 179
142. N.C. Nyborg, and P.J. Nielsen Angiotensin-II contracts isolated human posterior ciliary arteries Invest Ophthalmol Vis Sci 31 1990 2471 2473
143. N.C. Nyborg, P.J. Nielsen, D. Prieto, and S. Benedito Angiotensin II does not contract bovine retinal resistance arteries in vitro Exp Eye Res 50 1990 469 474
144. Y. Okada, I. Yamanaka, T. Sakamoto, Y. Hata, Y. Sassa, and H. Yoshikawa et al. Increased expression of angiotensin-converting enzyme in retinas of diabetic rats Jpn J Ophthalmol 45 2001 585 591
145. T. Okamura, Y. Wang, and N. Toda Local generation and action of angiotensin II in dog iris sphincter muscle Exp Eye Res 55 1992 563 568
146. Y. Okunuki, Y. Usui, N. Nagai, T. Kezuka, S. Ishida, and M. Takeuchi et al. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan Invest Ophthalmol Vis Sci 50 2009 2255 2261
147. T.M. Osicka, Y. Yu, V. Lee, S. Panagiotopoulos, B.E. Kemp, and G. Jerums Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery Clin Sci (Lond) 100 2001 249 257
148. R. Osusky, J. Nussberger, C. Amstutz, J. Flammer, and H.R. Brunner Individual measurements of angiotensin II concentrations in aqueous humor of the eye Eur J Ophthalmol 4 1994 228 233
149. A. Otani, H. Takagi, H. Oh, S. Koyama, and Y. Honda Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells Diabetes 50 2001 867 875
150. A. Otani, H. Takagi, K. Suzuma, and Y. Honda Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells Circ Res 82 1998 619 628
151. C. Ott, M.P. Schlaich, J. Harazny, B.M. Schmidt, G. Michelson, and R.E. Schmieder Effects of angiotensin II type 1-receptor blockade on retinal endothelial function J Hypertens 26 2008 516 522
152. M.A. Ozturk, M. Calguneri, S. Kiraz, I. Ertenli, A.M. Onat, and K. Ureten et al. Angiotensin-converting enzyme gene polymorphism in Behcet's disease Clin Rheumatol 23 2004 142 146
153. D.E. Palm, S.G. Shue, L.C. Keil, C.D. Balaban, and W.B. Severs Effects of angiotensin, vasopressin and atrial natriuretic peptide on intraocular pressure in anesthetized rats Neuropeptides 29 1995 193 203
154. A. Patel, S. Macmahon, J. Chalmers, B. Neal, M. Woodward, and L. Billot et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 2007 829 840
155. M. Paul, M.A. Poyan, and R. Kreutz Physiology of local renin-angiotensin systems Physiol Rev 86 2006 747 803
156. J.A. Phipps, J.L. Wilkinson-Berka, and E.L. Fletcher Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol Invest Ophthalmol Vis Sci 48 2007 927 934
157. M. Pons, S.W. Cousins, O. Alcazar, G.E. Striker, and M.E. Marin-Castano Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration Am J Pathol 178 2011 2665 2681
158. A. Pose-Reino, M. Rodriguez-Fernandez, B. Hayik, F. Gomez-Ulla, M.J. Carrera-Nouche, and F. Gude-Sampedro et al. Regression of alterations in retinal microcirculation following treatment for arterial hypertension J Clin Hypertens (Greenwich) 8 2006 590 595
159. D. Proud, J. Sweet, P. Stein, R.A. Settipane, A. Kagey-Sobotka, and M.H. Friedlaender et al. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen J Allergy Clin Immunol 85 1990 896 905
160. H.A. Quigley, and A.T. Broman The number of people with glaucoma worldwide in 2010 and 2020 Br J Ophthalmol 90 2006 262 267
161. M. Ramirez, E.A. Davidson, L. Luttenauer, P.P. Elena, F. Cumin, and G.A. Mathis et al. The renin-angiotensin system in the rabbit eye J Ocul Pharmacol Ther 12 1996 299 312
162. P.V. Rao, P. Deng, Y. Sasaki, and D.L. Epstein Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility Exp Eye Res 80 2005 197 206
163. C.F. Reilly, D.A. Tewksbury, N.M. Schechter, and J. Travis Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases J Biol Chem 257 1982 8619 8622
164. E.J. Rockwood, F. Fantes, E.B. Davis, and D.R. Anderson The response of retinal vasculature to angiotensin Invest Ophthalmol Vis Sci 28 1987 676 682
165. J.T. Rosenbaum, H.O. McDevitt, R.B. Guss, and P.R. Egbert Endotoxin-induced uveitis in rats as a model for human disease Nature 286 1980 611 613
166. P. Rouet-Benzineb, B. Gontero, P. Dreyfus, and C. Lafuma Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway J Mol Cell Cardiol 32 2000 1767 1778
167. H. Sakaguchi, S. Takai, M. Sakaguchi, T. Sugiyama, T. Ishihara, and Y. Yao et al. Chymase and angiotensin converting enzyme activities in a hamster model of glaucoma filtering surgery Curr Eye Res 24 2002 325 331
168. E. Sakurai, H. Taguchi, A. Anand, B.K. Ambati, E.S. Gragoudas, and J.W. Miller et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization Invest Ophthalmol Vis Sci 44 2003 2743 2749
169. S. Sarlos, B. Rizkalla, C.J. Moravski, Z. Cao, M.E. Cooper, and J.L. Wilkinson-Berka Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin Am J Pathol 163 2003 879 887
170. S. Sarlos, and J.L. Wilkinson-Berka The renin-angiotensin system and the developing retinal vasculature Invest Ophthalmol Vis Sci 46 2005 1069 1077
171. T. Sato, M. Niwa, A. Himeno, K. Tsutsumi, and T.T.I.Q.I.I. Amemiya Quantitative receptor autoradiographic analysis for angiotensin II receptors in bovine retinal microvessels: quantitation with radioluminography Cell Mol Neurobiol 13 1993 233 245
172. S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, and K. Noda et al. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization Invest Ophthalmol Vis Sci 48 2007 422 429
173. S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, and A. Fukamizu et al. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system Am J Pathol 173 2008 1911 1918
174. S. Satofuka, A. Ichihara, N. Nagai, K. Yamashiro, T. Koto, and H. Shinoda et al. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin Invest Ophthalmol Vis Sci 47 2006 2686 2692
175. S. Satofuka, A. Kanda, and S. Ishida Receptor-associated prorenin system in the pathogenesis of retinal diseases Front Biosci (Schol Ed) 4 2012 1449 1460
176. E. Savaskan, K.U. Loffler, F. Meier, F. Muller-Spahn, J. Flammer, and P. Meyer Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues Ophthalmic Res 36 2004 312 320
177. C. Savoia, D. Burger, N. Nishigaki, A. Montezano, and R.M. Touyz Angiotensin II and the vascular phenotype in hypertension Expert Rev Mol Med 13 2011 e11
178. U. Schonfelder, A. Hofer, M. Paul, and R.H. Funk In situ observation of living pericytes in rat retinal capillaries Microvasc Res 56 1998 22 29
179. P. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, and K. Nishiyama et al. Angiotensin II and its receptor subtypes in the human retina Invest Ophthalmol Vis Sci 48 2007 3301 3311
180. G.B. Shah, S. Sharma, A.A. Mehta, and R.K. Goyal Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma J Cardiovasc Pharmacol 36 2000 169 175
181. A. Sharma, D.I. Bettis, J.W. Cowden, and R.R. Mohan Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo Mol Vis 16 2010 720 728
182. K.K. Sharma, and B.J. Ortwerth Purification and characterization of prolyl oligopeptidase from bovine lens Exp Eye Res 59 1994 107 115
183. O.P. Sharma, and J.B. Vita Determination of angiotensin-converting enzyme activity in tears. A noninvasive test for evaluation of ocular sarcoidosis Arch Ophthalmol 101 1983 559 561
184. F. Shen, L. Zhang, and T. Liu Effects of angiotensin II on the 3H-TdR incorporation and synthesis of collagen in cultured bovine trabecular meshwork cells Yan Ke Xue Bao 17 2001 209 212
185. N. Shiota, Y. Saegusa, K. Nishimura, and M. Miyazaki Angiotensin II-generating system in dog and monkey ocular tissues Clin Exp Pharmacol Physiol 24 1997 243 248
186. A.K. Sjolie, P. Dodson, and F.R. Hobbs Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review Int J Clin Pract 65 2011 148 153
187. A.K. Sjolie, R. Klein, M. Porta, T. Orchard, J. Fuller, and H.H. Parving et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial Lancet 372 2008 1385 1393
188. A.K. Sjolie, R. Klein, M. Porta, T. Orchard, J. Fuller, and H.H. Parving et al. Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme Diabet Med 28 2011 345 351
189. D. Smidt, L. Torpet, B. Nauntofte, K. Heegaard, and A. Pedersen Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people Community Dent Oral Epidemiol 39 2011 276 288
190. N. Sossi, and D.R. Anderson Blockage of axonal transport in optic nerve induced by elevation of intraocular pressure. Effect of arterial hypertension induced by angiotensin I Arch Ophthalmol 101 1983 94 97
191. T. Spicher, S. Orgul, K. Gugleta, B. Teuchner, and J. Flammer The effect of losartan potassium on choroidal hemodynamics in healthy subjects J Glaucoma 11 2002 177 182
192. S.J. Sramek, I.H. Wallow, R.P. Day, and E.N. Ehrlich Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue Invest Ophthalmol Vis Sci 29 1988 1749 1752
193. S.J. Sramek, I.H. Wallow, D.A. Tewksbury, C.R. Brandt, and G.L. Poulsen An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen Invest Ophthalmol Vis Sci 33 1992 1627 1632
194. U.M. Steckelings, M. Larhed, A. Hallberg, R.E. Widdop, E.S. Jones, and C. Wallinder et al. Non-peptide AT2-receptor agonists Curr Opin Pharmacol 11 2011 187 192
195. J. Stone, T. Chan-Ling, J. Pe'er, A. Itin, H. Gnessin, and E. Keshet Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity Invest Ophthalmol Vis Sci 37 1996 290 299
196. G.E. Striker, F. Praddaude, O. Alcazar, S.W. Cousins, and M.E. Marin-Castano Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II Am J Physiol Cell Physiol 295 2008 C1633 C1646
197. S.M. Strittmatter, K.M. Braas, and S.H. Snyder Localization of angiotensin converting enzyme in the ciliary epithelium of the rat eye Invest Ophthalmol Vis Sci 30 1989 2209 2214
198. T. Sugiyama, T. Okuno, M. Fukuhara, H. Oku, T. Ikeda, and H. Obayashi et al. Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes Exp Eye Res 85 2007 406 412
199. Y. Suzuki, M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, V. Esteban, and J. Egido Inflammation and angiotensin II Int J Biochem Cell Biol 35 2003 881 900
200. S. Takai, D. Jin, and M. Miyazaki New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage J Pharmacol Sci 113 2010 301 309
201. M.C. Thomas, C. Tikellis, W.M. Burns, K. Bialkowski, Z. Cao, and M.T. Coughlan et al. Interactions between renin angiotensin system and advanced glycation in the kidney J Am Soc Nephrol 16 2005 2976 2984
202. L. Thorig, E.J. van Agtmaal, E. Glasius, K.L. Tan, and N.J. van Haeringen Comparison of tears and lacrimal gland fluid in the rabbit and guinea pig Curr Eye Res 4 1985 913 920
203. J.M. Tielsch, J. Katz, A. Sommer, H.A. Quigley, and J.C. Javitt Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment Arch Ophthalmol 113 1995 216 221
204. R. Tigerstedt, and P.G. Bergmann Niere und kreislauf Scand Arch Physiol 8 1898 223 271
205. C. Tikellis, C.I. Johnston, J.M. Forbes, W.C. Burns, M.C. Thomas, and R.A. Lew et al. Identification of angiotensin converting enzyme 2 in the rodent retina Curr Eye Res 29 2004 419 427
206. I. Toma, J.J. Kang, A. Sipos, S. Vargas, E. Bansal, and F. Hanner et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney J Clin Invest 118 2008 2526 2534
207. Y. Tomino, Y. Makita, T. Shike, T. Gohda, M. Haneda, and R. Kikkawa et al. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients Nephron 82 1999 139 144
208. E.G. Udupa, and N.M. Rao Distribution and some properties of sheep (Ovis aries) angiotension converting enzyme Biochem Mol Biol Int 31 1993 851 859
209. UK Prospective Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 317 1998 703 713
210. H. Urata, B. Healy, R.W. Stewart, F.M. Bumpus, and A. Husain Angiotensin II-forming pathways in normal and failing human hearts Circ Res 66 1990 883 890
211. T. Usui, K. Sugisaki, A. Iriyama, S. Yokoo, S. Yamagami, and N. Nagai et al. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor Invest Ophthalmol Vis Sci 49 2008 4370 4376
212. A. Vaajanen, S. Luhtala, O. Oksala, and H. Vapaatalo Does the renin-angiotensin system also regulate intra-ocular pressure? Ann Med 40 2008 418 427
213. A. Vaajanen, E. Mervaala, O. Oksala, and H. Vapaatalo Is there a relationship between blood pressure and intraocular pressure? An experimental study in hypertensive rats Curr Eye Res 33 2008 325 332
214. A. Vaajanen, H. Vapaatalo, H. Kautiainen, and O. Oksala Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye Invest Ophthalmol Vis Sci 49 2008 2557 2562
215. A. Verma, Z. Shan, B. Lei, L. Yuan, X. Liu, and T. Nakagawa et al. ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy Mol Ther 20 2012 28 36
216. J.B. Vita, J.A. Anderson, C.D. Hulem, and I.H. Leopold Angiotensin-converting enzyme activity in ocular fluids Invest Ophthalmol Vis Sci 20 1981 255 257
217. B.P. Vogh, and D.R. Godman Effects of inhibition of angiotensin converting enzyme and carbonic anhydrase on fluid production by ciliary process, choroid plexus, and pancreas J Ocul Pharmacol 5 1989 303 311
218. O.V. Volpert, W.F. Ward, M.W. Lingen, L. Chesler, D.B. Solt, and M.D. Johnson et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats J Clin Invest 98 1996 671 679
219. I.H. Wallow, S.J. Sramek, C.D. Bindley, S.R. Darjatmoko, and S.J. Gange Ocular renin angiotensin: EM immunocytochemical localization of prorenin Curr Eye Res 12 1993 945 950
220. D. Wang, J.R. Martens, P. Posner, C. Sumners, and C.H. Gelband Angiotensin II regulation of intracellular calcium in astroglia cultured from rat hypothalamus and brainstem J Neurochem 67 1996 996 1004
221. R.F. Wang, S.M. Podos, T.W. Mittag, and T. Yokoyoma Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes Exp Eye Res 80 2005 629 632
222. S. Wang, L. Xu, J.B. Jonas, T.Y. Wong, T. Cui, and Y. Li et al. Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study Ophthalmology 116 2009 2373 2380
223. R.W. Watkins, T. Baum, K. Cedeno, E.M. Smith, P.H. Yuen, and H.S. Ahn et al. Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits J Ocul Pharmacol 3 1987 295 307
224. C.C. Wei, N. Hase, Y. Inoue, E.W. Bradley, E. Yahiro, and M. Li et al. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents J Clin Invest 120 2010 1229 1239
225. R.N. Weinreb, J.R. Polansky, S.G. Kramer, and J.D. Baxter Acute effects of dexamethasone on intraocular pressure in glaucoma Invest Ophthalmol Vis Sci 26 1985 170 175
226. T.H. Wheeler-Schilling, K. Kohler, M. Sautter, and E. Guenther Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat Eur J Neurosci 11 1999 3387 3394
227. T.H. Wheeler-Schilling, M. Sautter, E. Guenther, and K. Kohler Expression of angiotensin-converting enzyme (ACE) in the developing chicken retina Exp Eye Res 72 2001 173 182
228. J.L. Wilkinson-Berka, A. Agrotis, and D. Deliyanti The retinal renin-angiotensin system: roles of angiotensin II and aldosterone Peptides 36 2012 142 150
229. J.L. Wilkinson-Berka, R. Heine, G. Tan, M.E. Cooper, K.M. Hatzopoulos, and E.L. Fletcher et al. RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina Hypertension 55 2010 1454 1460
230. J.L. Wilkinson-Berka, A.G. Miller, and K.J. Binger Prorenin and the (pro)renin receptor: recent advances and implications for retinal development and disease Curr Opin Nephrol Hypertens 20 2011 69 76
231. J.L. Wilkinson-Berka, I. Rana, R. Armani, and A. Agrotis Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy Clin Sci (Lond) 124 2013 597 615
232. J.L. Wilkinson-Berka, G. Tan, K.J. Binger, L. Sutton, K. McMaster, and D. Deliyanti et al. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat Diabetologia 54 2011 2724 2735
233. J.L. Wilkinson-Berka, G. Tan, K. Jaworski, and A.G. Miller Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology Circ Res 104 2009 124 133
234. J.L. Wilkinson-Berka, G. Tan, K. Jaworski, and S. Ninkovic Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina Am J Hypertens 20 2007 423 430
235. S. Yaguchi, Y. Ogawa, S. Shimmura, S. Hatou, S. Nakamura, and T. Inaba et al. Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland Invest Ophthalmol Vis Sci 53 2012 5416 5425
236. S. Yamagishi, S. Amano, Y. Inagaki, T. Okamoto, H. Inoue, and M. Takeuchi et al. Angiotensin II-type 1 receptor interaction upregulates vascular endothelial growth factor messenger RNA levels in retinal pericytes through intracellular reactive oxygen species generation Drugs Exp Clin Res 29 2003 75 80
237. S. Yamagishi, M. Takeuchi, T. Matsui, K. Nakamura, T. Imaizumi, and H. Inoue Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression FEBS Lett 579 2005 4265 4270
238. H. Yang, K. Hirooka, K. Fukuda, and F. Shiraga Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma Invest Ophthalmol Vis Sci 50 2009 5800 5804
239. S. Yasar, J. Xia, W. Yao, C.D. Furberg, Q.L. Xue, and C.I. Mercado et al. Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study Neurology 81 2013 896 903
240. J.W. Yau, S.L. Rogers, R. Kawasaki, E.L. Lamoureux, J.W. Kowalski, and T. Bek et al. Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 35 2012 556 564
241. H. Yokota, F. Mori, K. Kai, T. Nagaoka, N. Izumi, and A. Takahashi et al. Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay Br J Ophthalmol 89 2005 871 873
242. H. Yokota, T. Nagaoka, F. Mori, T. Hikichi, H. Hosokawa, and H. Tanaka et al. Prorenin levels in retinopathy of prematurity Am J Ophthalmol 143 2007 531 533
243. J.Z. Zhang, L. Gao, M. Widness, X. Xi, and T.S. Kern Captopril inhibits glucose accumulation in retinal cells in diabetes Invest Ophthalmol Vis Sci 44 2003 4001 4005
244. X. Zhang, M. Lassila, M.E. Cooper, and Z. Cao Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors Hypertension 43 2004 276 281
245. K. Zhang, L. Zhang, and R.N. Weinreb Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma Nat Rev Drug Discov 11 2012 541 559
246. Z. Zheng, H. Chen, G. Ke, Y. Fan, H. Zou, and X. Sun et al. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway Diabetes 58 2009 954 964
247. C.H. Zhu, S.S. Zhang, Y. Kong, Y.F. Bi, L. Wang, and Q. Zhang Effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with type II diabetes mellitus Int J Ophthalmol 6 2013 141 145